- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan RNAi For Therapeutic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan RNAi For Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by RNAi For Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
RXi Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
Dicerna Pharmaceuticals
Alnylam Pharmaceuticals
Sirnaomics
MiRagen Therapeutics
Gradalis
Arrowhead
By Type:
siRNA
miRNA
shRNA
By End-User:
Cancer
Cardiovascular
HBV
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi For Therapeutic Market
-
1.3 Market Segment by Type
1.3.1 Japan RNAi For Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
1.3.2 Japan RNAi For Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
1.3.3 Japan RNAi For Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan RNAi For Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
1.4.2 Japan RNAi For Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
1.4.3 Japan RNAi For Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of RNAi For Therapeutic Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNAi For Therapeutic by Major Types
3.4.1 Market Size and Growth Rate of siRNA
3.4.2 Market Size and Growth Rate of miRNA
3.4.3 Market Size and Growth Rate of shRNA
4 Segmentation of RNAi For Therapeutic Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNAi For Therapeutic by Major End-Users
4.4.1 Market Size and Growth Rate of RNAi For Therapeutic in Cancer
4.4.2 Market Size and Growth Rate of RNAi For Therapeutic in Cardiovascular
4.4.3 Market Size and Growth Rate of RNAi For Therapeutic in HBV
5 Market Analysis by Regions
-
5.1 Japan RNAi For Therapeutic Production Analysis by Regions
-
5.2 Japan RNAi For Therapeutic Consumption Analysis by Regions
6 Hokkaido RNAi For Therapeutic Landscape Analysis
-
6.1 Hokkaido RNAi For Therapeutic Landscape Analysis by Major Types
-
6.2 Hokkaido RNAi For Therapeutic Landscape Analysis by Major End-Users
7 Tohoku RNAi For Therapeutic Landscape Analysis
-
7.1 Tohoku RNAi For Therapeutic Landscape Analysis by Major Types
-
7.2 Tohoku RNAi For Therapeutic Landscape Analysis by Major End-Users
8 Kanto RNAi For Therapeutic Landscape Analysis
-
8.1 Kanto RNAi For Therapeutic Landscape Analysis by Major Types
-
8.2 Kanto RNAi For Therapeutic Landscape Analysis by Major End-Users
9 Chubu RNAi For Therapeutic Landscape Analysis
-
9.1 Chubu RNAi For Therapeutic Landscape Analysis by Major Types
-
9.2 Chubu RNAi For Therapeutic Landscape Analysis by Major End-Users
10 Kinki RNAi For Therapeutic Landscape Analysis
-
10.1 Kinki RNAi For Therapeutic Landscape Analysis by Major Types
-
10.2 Kinki RNAi For Therapeutic Landscape Analysis by Major End-Users
11 Chugoku RNAi For Therapeutic Landscape Analysis
-
11.1 Chugoku RNAi For Therapeutic Landscape Analysis by Major Types
-
11.2 Chugoku RNAi For Therapeutic Landscape Analysis by Major End-Users
12 Shikoku RNAi For Therapeutic Landscape Analysis
-
12.1 Shikoku RNAi For Therapeutic Landscape Analysis by Major Types
-
12.2 Shikoku RNAi For Therapeutic Landscape Analysis by Major End-Users
13 Kyushu RNAi For Therapeutic Landscape Analysis
-
13.1 Kyushu RNAi For Therapeutic Landscape Analysis by Major Types
-
13.2 Kyushu RNAi For Therapeutic Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 RXi Pharmaceuticals
14.1.1 RXi Pharmaceuticals Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Mirna Therapeutics
14.2.1 Mirna Therapeutics Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Quark Pharmaceuticals
14.3.1 Quark Pharmaceuticals Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Dicerna Pharmaceuticals
14.4.1 Dicerna Pharmaceuticals Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Alnylam Pharmaceuticals
14.5.1 Alnylam Pharmaceuticals Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Sirnaomics
14.6.1 Sirnaomics Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 MiRagen Therapeutics
14.7.1 MiRagen Therapeutics Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Gradalis
14.8.1 Gradalis Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Arrowhead
14.9.1 Arrowhead Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
The List of Tables and Figures (Totals 122 Figures and 161 Tables)
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu RNAi For Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of RNAi For Therapeutic Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of RNAi For Therapeutic
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNAi For Therapeutic by Different Types from 2014 to 2026
-
Table Consumption Share of RNAi For Therapeutic by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of siRNA
Figure Market Size and Growth Rate of miRNA
Figure Market Size and Growth Rate of shRNA
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of RNAi For Therapeutic by Different End-Users from 2014 to 2026
-
Table Consumption Share of RNAi For Therapeutic by Different End-Users from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan RNAi For Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
-
Table Japan RNAi For Therapeutic Production by Regions
-
Table Japan RNAi For Therapeutic Production Share by Regions
-
Figure Japan RNAi For Therapeutic Production Share by Regions in 2014
-
Figure Japan RNAi For Therapeutic Production Share by Regions in 2018
-
Figure Japan RNAi For Therapeutic Production Share by Regions in 2026
-
Table Japan RNAi For Therapeutic Consumption by Regions
-
Table Japan RNAi For Therapeutic Consumption Share by Regions
-
Figure Japan RNAi For Therapeutic Consumption Share by Regions in 2014
-
Figure Japan RNAi For Therapeutic Consumption Share by Regions in 2018
-
Figure Japan RNAi For Therapeutic Consumption Share by Regions in 2026
-
Table Hokkaido RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Hokkaido RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Hokkaido RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Hokkaido RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Hokkaido RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Tohoku RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Tohoku RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Tohoku RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Tohoku RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Tohoku RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Tohoku RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Tohoku RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Tohoku RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Tohoku RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Kanto RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Kanto RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kanto RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Kanto RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Kanto RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Kanto RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kanto RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Kanto RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Kanto RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Chubu RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Chubu RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Chubu RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Chubu RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Chubu RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Chubu RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Chubu RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Chubu RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Chubu RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Kinki RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Kinki RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kinki RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Kinki RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Kinki RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Kinki RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kinki RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Kinki RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Kinki RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Chugoku RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Chugoku RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Chugoku RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Chugoku RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Chugoku RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Chugoku RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Chugoku RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Chugoku RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Chugoku RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Shikoku RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Shikoku RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Shikoku RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Shikoku RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Shikoku RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Shikoku RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Shikoku RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Shikoku RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Shikoku RNAi For Therapeutic Consumption Share by End-Users in 2026
-
Table Kyushu RNAi For Therapeutic Consumption by Types from 2014 to 2026
-
Table Kyushu RNAi For Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kyushu RNAi For Therapeutic Consumption Share by Types in 2014
-
Figure Kyushu RNAi For Therapeutic Consumption Share by Types in 2018
-
Figure Kyushu RNAi For Therapeutic Consumption Share by Types in 2026
-
Table Kyushu RNAi For Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kyushu RNAi For Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu RNAi For Therapeutic Consumption Share by End-Users in 2014
-
Figure Kyushu RNAi For Therapeutic Consumption Share by End-Users in 2018
-
Figure Kyushu RNAi For Therapeutic Consumption Share by End-Users in 2026
Table Company Profile and Development Status of RXi Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals
Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals
Figure Revenue and Market Share Analysis of RXi Pharmaceuticals
Table Product and Service Introduction of RXi Pharmaceuticals
Table Company Profile and Development Status of Mirna Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirna Therapeutics
Figure Sales and Growth Rate Analysis of Mirna Therapeutics
Figure Revenue and Market Share Analysis of Mirna Therapeutics
Table Product and Service Introduction of Mirna Therapeutics
Table Company Profile and Development Status of Quark Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals
Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals
Figure Revenue and Market Share Analysis of Quark Pharmaceuticals
Table Product and Service Introduction of Quark Pharmaceuticals
Table Company Profile and Development Status of Dicerna Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals
Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals
Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals
Table Product and Service Introduction of Dicerna Pharmaceuticals
Table Company Profile and Development Status of Alnylam Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
Table Product and Service Introduction of Alnylam Pharmaceuticals
Table Company Profile and Development Status of Sirnaomics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics
Figure Sales and Growth Rate Analysis of Sirnaomics
Figure Revenue and Market Share Analysis of Sirnaomics
Table Product and Service Introduction of Sirnaomics
Table Company Profile and Development Status of MiRagen Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MiRagen Therapeutics
Figure Sales and Growth Rate Analysis of MiRagen Therapeutics
Figure Revenue and Market Share Analysis of MiRagen Therapeutics
Table Product and Service Introduction of MiRagen Therapeutics
Table Company Profile and Development Status of Gradalis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis
Figure Sales and Growth Rate Analysis of Gradalis
Figure Revenue and Market Share Analysis of Gradalis
Table Product and Service Introduction of Gradalis
Table Company Profile and Development Status of Arrowhead
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead
Figure Sales and Growth Rate Analysis of Arrowhead
Figure Revenue and Market Share Analysis of Arrowhead
Table Product and Service Introduction of Arrowhead
-